Suppr超能文献

FGF-23 调节肾脏和肾脏外组织中 CYP27B1 的转录。

FGF-23 regulates CYP27B1 transcription in the kidney and in extra-renal tissues.

机构信息

Department of Pediatrics, University of California San Francisco, San Francisco, California, United States of America.

出版信息

PLoS One. 2013 Sep 3;8(9):e72816. doi: 10.1371/journal.pone.0072816. eCollection 2013.

Abstract

The mitochondrial enzyme 25-hydroxyvitamin D 1α-hydroxylase, which is encoded by the CYP27B1 gene, converts 25OHD to the biological active form of vitamin D, 1,25-dihydroxyvitamin D (1,25(OH)2D). Renal 1α-hydroxylase activity is the principal determinant of the circulating 1,25(OH)2D concentration and enzyme activity is tightly regulated by several factors. Fibroblast growth factor-23 (FGF-23) decreases serum 1,25(OH)2D concentrations by suppressing CYP27B1 mRNA abundance in mice. In extra-renal tissues, 1α-hydroxylase is responsible for local 1,25(OH)2D synthesis, which has important paracrine actions, but whether FGF-23 regulates CYP27B1 gene expression in extra-renal tissues is unknown. We sought to determine whether FGF-23 regulates CYP27B1 transcription in the kidney and whether extra-renal tissues are target sites for FGF-23-induced suppression of CYP27B1. In HEK293 cells transfected with the human CYP27B1 promoter, FGF-23 suppressed promoter activity by 70%, and the suppressive effect was blocked by CI-1040, a specific inhibitor of extracellular signal regulated kinase 1/2. To examine CYP27B1 transcriptional activity in vivo, we crossed fgf-23 null mice with mice bearing the CYP27B1 promoter-driven luciferase transgene (1α-Luc). In the kidney of FGF-23 null/1α-Luc mice, CYP27B1 promoter activity was increased by 3-fold compared to that in wild-type/1α-Luc mice. Intraperitoneal injection of FGF-23 suppressed renal CYP27B1 promoter activity and protein expression by 26% and 60% respectively, and the suppressive effect was blocked by PD0325901, an ERK1/2 inhibitor. These findings provide evidence that FGF-23 suppresses CYP27B1 transcription in the kidney. Furthermore, we demonstrate that in FGF-23 null/1α-Luc mice, CYP27B1 promoter activity and mRNA abundance are increased in several extra-renal sites. In the heart of FGF-23 null/1α-Luc mice, CYP27B1 promoter activity and mRNA were 2- and 5-fold higher, respectively, than in control mice. We also observed a 3- to 10-fold increase in CYP27B1 mRNA abundance in the lung, spleen, aorta and testis of FGF-23 null/1α-Luc mice. Thus, we have identified novel extra-renal target sites for FGF-23-mediated regulation of CYP27B1.

摘要

线粒体酶 25-羟维生素 D1α-羟化酶由 CYP27B1 基因编码,可将 25OHD 转化为维生素 D 的生物活性形式,1,25-二羟维生素 D(1,25(OH)2D)。肾脏 1α-羟化酶活性是循环 1,25(OH)2D 浓度的主要决定因素,酶活性受多种因素的严格调节。成纤维细胞生长因子 23(FGF-23)通过抑制小鼠 CYP27B1 mRNA 丰度降低血清 1,25(OH)2D 浓度。在肾脏外组织中,1α-羟化酶负责局部 1,25(OH)2D 的合成,具有重要的旁分泌作用,但 FGF-23 是否调节肾脏外组织中的 CYP27B1 基因表达尚不清楚。我们试图确定 FGF-23 是否调节肾脏中的 CYP27B1 转录,以及肾脏外组织是否是 FGF-23 诱导的 CYP27B1 抑制的靶位点。在转染人 CYP27B1 启动子的 HEK293 细胞中,FGF-23 抑制启动子活性达 70%,CI-1040(一种细胞外信号调节激酶 1/2 的特异性抑制剂)阻断了这种抑制作用。为了在体内检查 CYP27B1 的转录活性,我们将 fgf-23 缺失小鼠与携带 CYP27B1 启动子驱动的荧光素酶转基因(1α-Luc)的小鼠杂交。在 FGF-23 缺失/1α-Luc 小鼠的肾脏中,CYP27B1 启动子活性比野生型/1α-Luc 小鼠增加了 3 倍。FGF-23 的腹腔内注射抑制了肾脏 CYP27B1 启动子活性和蛋白表达分别为 26%和 60%,并且 ERK1/2 抑制剂 PD0325901 阻断了这种抑制作用。这些发现为 FGF-23 抑制肾脏中的 CYP27B1 转录提供了证据。此外,我们证明在 FGF-23 缺失/1α-Luc 小鼠中,CYP27B1 启动子活性和 mRNA 丰度在多个肾脏外部位增加。在 FGF-23 缺失/1α-Luc 小鼠的心脏中,CYP27B1 启动子活性和 mRNA 分别比对照小鼠高 2 倍和 5 倍。我们还观察到 FGF-23 缺失/1α-Luc 小鼠的肺、脾、主动脉和睾丸中 CYP27B1 mRNA 丰度增加了 3 到 10 倍。因此,我们已经确定了 FGF-23 介导的 CYP27B1 调节的新的肾脏外靶位点。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cb1d/3760837/7646a37a5e90/pone.0072816.g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验